Deciphering the male breast cancer genome

Researchers at Cornell University in New York have made a significant breakthrough by sequencing the male breast cancer genome for the first time. The study, published in the journal Modern Pathology, revealed genomic alterations specific to this male cancer, distinct from those found in women, and identified potential new therapeutic targets.